Blood cancer Clinical Trials in Omaha, NE
As of August 2026, 43 paid clinical trials are recruiting for Blood cancer in Omaha, Nebraska. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
43 clinical trials for Blood cancer
·Clear filters·Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Halt Aging in Survivors of Blood Cancers
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Integrated Cancer Repository for Cancer Research
Top Research Study Locations in Omaha
Researchers run research studies in Omaha, NE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Nebraska Medical Center | Acute Myeloid Leukemia, Multiple Myeloma, Breast Cancer | 217 |
| Nebraska Cancer Specialists | Breast Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer | 41 |
| Nebraska Medicine-Village Pointe | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 | 38 |
| Children's Hospital and Medical Center of Omaha | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 28 |
| Nebraska Methodist Hospital | Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma | 28 |
| Alegent Health Bergan Mercy Medical Center | Malignant Solid Neoplasm, Plasma Cell Myeloma, Prostate Adenocarcinoma | 22 |
| Alegent Health Immanuel Medical Center | Malignant Solid Neoplasm, Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma | 20 |
| Alegent Health Lakeside Hospital | Malignant Solid Neoplasm, Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma | 20 |
| Nebraska Cancer Specialists/Oncology Hematology West PC - MECC | Ovarian Carcinoma, Stage II Lip and Oral Cavity Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 | 14 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Chronic Obstructive Pulmonary Disease, Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD) | 13 |
| University of Nebraska | Adenocarcinoma, Pancreatic Ductal, Adenovirus Infections, Brain Tumor | 12 |
| Creighton University Medical Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 10 |
| Creighton University | Age-associated Muscle Loss, Anxiety and Mood Disorders, Bilateral Vestibular Hypofunction | 8 |
| Boys Town National Research Hospital | Developmental Language Disorder, Autism, Autism Spectrum Disorder | 7 |
| Nebraska Medicine | Cachexia, Choline Deficiency, Engagement | 7 |
| Children's Nebraska | Acute Kidney Injury, Bronchiolitis Acute, Chronic Kidney Disease(CKD) | 6 |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 6 |
| GSK Investigational Site | Colonic Neoplasms, Gastrointestinal Neoplasms, Gastrointestinal Stromal Neoplasms | 5 |
| Nebraska Medical Center | Atrial Fibrillation, Cardiac Arrest, Cardiopulmonary Arrest | 5 |
| Unversity of Nebraska Medical Center | Chronic Pancreatitis, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease | 4 |
| Oncology Hematology West, PC dba Nebraska Cancer Specialists | Follicular Lymphoma (FL), Metastatic Castration Resistant Prostate Cancer (mCRPC), Refractory Diffuse Large B-cell Lymphoma | 4 |
| Children's Hospital & Medical Center | Acute Treatment of Migraine, Pediatric Migraine | 3 |
| Fred & Pamela Buffet Cancer Center | Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT), Diffuse Large B-Cell Lymphoma, Prostate Adenocarcinoma | 3 |
| Skin Specialists, PC dba Schlessinger MD | Atopic Dermatitis, Hidradenitis Suppurativa, Severe Alopecia Areata | 3 |
| Vance Thompson Vision | Age-Related Macular Degeneration, Astigmatism, Geographic Atrophy | 3 |
Active & Upcoming Studies in Omaha (2026)
Recruiting trials in Omaha grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (257 active studies)
- Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · University of Nebraska
- WATER IV PCa (AS Sub-study) · PROCEPT BioRobotics
Cardiovascular (38 active studies)
- Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest · Phase 3 · Invero Pharma, Inc.
- Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids · Phase 1, Phase 2 · University of Nebraska
Diabetes & metabolic (18 active studies)
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (15 active studies)
- Clinical Validation of Self-Pacing Algorithms on Step Length Symmetry in Hemiplegic Populations · Quality Living, Inc.
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
Pediatric (7 active studies)
- Evaluating the Effects of an Electrical Stimulator on Improving the Walking Ability of Children With Cerebral Palsy · University of Nebraska
- iAmHealthy Clinical Practice Guideline (CPG) · University of Kansas Medical Center
Vaccines (6 active studies)
- A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) · Phase 1, Phase 2 · AstraZeneca
- Heat thErapy And mobiLity in COVID-19 Survivors · University of Nebraska
Eye & vision (6 active studies)
- A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK · Phase 4 · Vance Thompson Vision
- The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma · Vance Thompson Vision
Mental health & behavior (4 active studies)
- The Impact of Enhanced Music & Natural Visuals on Emotional Health · soundBrilliance LLC
- Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) · Bristol-Myers Squibb
HIV / STI (2 active studies)
Common conditions studied in Omaha
- Breast Cancer (16 active studies)
- Multiple Myeloma (14 active studies)
- Prostate Cancer (14 active studies)
- Non-Small Cell Lung Cancer (11 active studies)
- Ovarian Cancer (10 active studies)
- Heart Failure (9 active studies)
Leading research sponsors in Omaha
- University of Nebraska
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Omaha?
There are approximately 584 recruiting clinical trials in Omaha, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Omaha pay participants?
Most recruiting trials in Omaha compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Omaha?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Omaha?
The most common conditions under active study in Omaha include Breast Cancer (16), Multiple Myeloma (14), Prostate Cancer (14), Non-Small Cell Lung Cancer (11), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Omaha?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Omaha on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Omaha?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Omaha?
Recruiting research sites in Omaha include University of Nebraska Medical Center, Nebraska Cancer Specialists, Nebraska Medicine-Village Pointe, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Omaha right now?
The largest active categories in Omaha are Cancer & tumors (257), Cardiovascular (38), Diabetes & metabolic (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.